These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6939365)

  • 1. Bromodeoxyuridine-induced changes in the transformed phenotype.
    Avdalovic N
    Ann N Y Acad Sci; 1980; 349():346-56. PubMed ID: 6939365
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on antagonistic actions of TPA and retinoic acid.
    Jetten AM; De Luca LM
    Carcinog Compr Surv; 1982; 7():513-8. PubMed ID: 6978181
    [No Abstract]   [Full Text] [Related]  

  • 3. Retinoic acid induces anchorage- and density- dependent growth without restoring normal cytoskeleton, EGF binding, fibronectin content and ODC activity in a retrovirus- transformed mouse cell line.
    Mukherjee BB; Mobry PM; Pena SD
    Exp Cell Res; 1982 Mar; 138(1):95-107. PubMed ID: 6978257
    [No Abstract]   [Full Text] [Related]  

  • 4. Ornithine decarboxylase induction and the cytoskeleton in normal and transformed cells.
    Rumsby G; Puck TT
    J Cell Physiol; 1982 May; 111(2):133-9. PubMed ID: 7085773
    [No Abstract]   [Full Text] [Related]  

  • 5. Membrane glycopeptides from chemically transformed cells: comparison between mesenchymal and epithelial cell lines derived from dimethylnitrosamine-treated rat kidney.
    Rachesky MH; Hard GC; Glick MC
    Cancer Res; 1982 Jan; 42(1):39-43. PubMed ID: 7053865
    [No Abstract]   [Full Text] [Related]  

  • 6. Neoplastic transformation of rat liver epithelial cells in culture.
    Montesano R; Bannikov G; Drevon C; Kuroki T; Saint Vincent L; Tomatis L
    Ann N Y Acad Sci; 1980; 349():323-31. PubMed ID: 6111973
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlated suppression by 5-bromodeoxyuridine of tumorigenicity and plasminogen activator in mouse melanoma cells.
    Christman JK; Silagi S; Newcomb EW; Silverstein SC; Acs G
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):47-50. PubMed ID: 123336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some effects of 5-bromodeoxyuridine on polyoma-transformed mouse cells.
    Grady LJ; North AB
    Exp Cell Res; 1974 Jul; 87(1):120-6. PubMed ID: 4366852
    [No Abstract]   [Full Text] [Related]  

  • 9. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/cyclin-dependent kinases.
    Chen SC; Pelletier DB; Ao P; Boynton AL
    Cell Growth Differ; 1995 Jun; 6(6):681-90. PubMed ID: 7669722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible "transformation" of bromodeoxyuridine-dependent cells by bromodeoxyuridine.
    Davidson RL; Horn D
    Proc Natl Acad Sci U S A; 1974 Sep; 71(9):3338-42. PubMed ID: 4530304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of plasminogen activator from the transformed phenotype in a 5-bromodeoxyuridine dependent mutant of Syrian hamster melanoma cells.
    Rosenthal SL; Zucker D; Davidson RL
    J Cell Physiol; 1978 Jun; 95(3):275-85. PubMed ID: 649664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromodeoxyuridine treatment of rat liver cells in culture induces an increased metabolic conversion of exogenous ornithine.
    Avdalovic N; Hoshino M
    Biochem Biophys Res Commun; 1985 Jun; 129(3):746-52. PubMed ID: 4015653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Bromo-2'-deoxyuridine potentiation of transformation of rat-embryo cells induced in vitro by 3-methylcholanthrene: induction of rat leukemia virus gs antigen in transformed cells.
    Freeman AE; Gilden RV; Vernon ML; Wolford RG; Hugunin PE; Huebner RJ
    Proc Natl Acad Sci U S A; 1973 Aug; 70(8):2415-9. PubMed ID: 4134493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of overexpression of ornithine decarboxylase (ODC) on growth control and oncogene-induced cell transformation.
    Hibshoosh H; Johnson M; Weinstein IB
    Oncogene; 1991 May; 6(5):739-43. PubMed ID: 1711188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of diethylstilbestrol on the transformable mouse embryo fibroblast C3H/10T1/2C18 cells. Tumor promotion, cell growth, DNA synthesis, and ornithine decarboxylase.
    Lillehaug JR; Djurhuus R
    Carcinogenesis; 1982; 3(7):797-9. PubMed ID: 7116574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of SV40 T antigen in transformed hamster cells by chronic treatment with 5-bromo-2-deoxyuridine.
    Kreider JW; Del Villano B; Shoff WH; Davidson EA
    Cancer Res; 1972 Oct; 32(10):2148-55. PubMed ID: 4343009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the growth characteristics of mouse and rat fibroblasts during tumor progression].
    Lavrovskiĭ VA; Dobrunova EP; Shcherbakov AE
    Eksp Onkol; 1989; 11(3):43-6. PubMed ID: 2752942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulation of ornithine decarboxylase during oncogenic transformation: mechanisms and therapeutic potential.
    Shantz LM; Levin VA
    Amino Acids; 2007 Aug; 33(2):213-23. PubMed ID: 17443268
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cell surface. An important topic in cancer research].
    Larsen B
    Ugeskr Laeger; 1973 May; 135(22):1076-8. PubMed ID: 4585742
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.